Cite
HARVARD Citation
Maurer, M. et al. (2018). Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials. Annals of oncology. pp. 1822-1827. [Online].